Literature DB >> 24463189

Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.

Frederic Rahbari-Oskoui1, Olubunmi Williams1, Arlene Chapman1.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease, characterized by progressive cyst growth and renal enlargement, resulting in renal failure. Hypertension is common and occurs early, prior to loss of kidney function. Whether hypertension in ADPKD is a primary vasculopathy secondary to mutations in the polycystin genes or secondary to activation of the renin-angiotensin-aldosterone system by cyst expansion and intrarenal ischemia is unclear. Dysregulation of the primary cilium causing endothelial and vascular smooth muscle cell dysfunction is a component of ADPKD. In this article, we review the epidemiology, pathophysiology and clinical characteristics of hypertension in ADPKD and give specific recommendations for its treatment.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  autosomal dominant polycystic kidney disease; endothelial dysfunction; hypertension; renin–angiotensin–aldosterone system; treatment

Mesh:

Year:  2014        PMID: 24463189     DOI: 10.1093/ndt/gft513

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

1.  Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere.

Authors:  M Niemczyk
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

Review 2.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

Review 3.  The functions of TRPP2 in the vascular system.

Authors:  Juan Du; Jie Fu; Xian-ming Xia; Bing Shen
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

4.  Role of Intrinsic (Graft) Versus Extrinsic (Host) Factors in the Growth of Transplanted Organs Following Allogeneic and Xenogeneic Transplantation.

Authors:  T Tanabe; H Watanabe; J A Shah; H Sahara; A Shimizu; S Nomura; A Asfour; M Danton; L Boyd; A Dardenne Meyers; D K Ekanayake-Alper; D H Sachs; K Yamada
Journal:  Am J Transplant       Date:  2017-03-03       Impact factor: 8.086

5.  Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Ryohei Miyamoto; Akinari Sekine; Takuya Fujimaru; Tatsuya Suwabe; Hiroki Mizuno; Eiko Hasegawa; Masayuki Yamanouchi; Motoko Chiga; Takayasu Mori; Eisei Sohara; Shinichi Uchida; Naoki Sawa; Yoshifumi Ubara; Junichi Hoshino
Journal:  Kidney Dis (Basel)       Date:  2021-11-26

6.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

Review 7.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

8.  Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout.

Authors:  Bruno E Balbo; Andressa G Amaral; Jonathan M Fonseca; Isac de Castro; Vera M Salemi; Leandro E Souza; Fernando Dos Santos; Maria C Irigoyen; Feng Qian; Roger Chammas; Luiz F Onuchic
Journal:  Kidney Int       Date:  2016-07-27       Impact factor: 10.612

9.  Rare coding variants associated with blood pressure variation in 15 914 individuals of African ancestry.

Authors:  Priyanka Nandakumar; Dongwon Lee; Melissa A Richard; Fasil Tekola-Ayele; Bamidele O Tayo; Erin Ware; Yun J Sung; Babatunde Salako; Adesola Ogunniyi; C Charles Gu; Megan L Grove; Myriam Fornage; Sharon Kardia; Charles Rotimi; Richard S Cooper; Alanna C Morrison; Georg Ehret; Aravinda Chakravarti
Journal:  J Hypertens       Date:  2017-07       Impact factor: 4.776

10.  The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function.

Authors:  Cuma Bulent Gul; Abdulmecit Yildiz; Saim Sag; Aysegul Oruc; Alparslan Ersoy; Sumeyye Gullulu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.